Within genome variation of germ-line and somatic mutation

Variation in the mutation rate along the human genome, if not properly understood and accounted for, has the potential to confound evolutionary studies, produce spurious driver candidates in cancer studies, and hinder the diagnostics aimed at understanding the etiologies of genetic diseases. In this...

Full description

Bibliographic Details
Main Author: Smith, Thomas C. A.
Published: University of Sussex 2017
Subjects:
611
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.714797
id ndltd-bl.uk-oai-ethos.bl.uk-714797
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-7147972019-03-05T15:23:09ZWithin genome variation of germ-line and somatic mutationSmith, Thomas C. A.2017Variation in the mutation rate along the human genome, if not properly understood and accounted for, has the potential to confound evolutionary studies, produce spurious driver candidates in cancer studies, and hinder the diagnostics aimed at understanding the etiologies of genetic diseases. In this thesis I consider mutation rate variation in both the germ-line and somatic tissues, at varying scales. In the germ-line, the major advance of this thesis over previous works is use of direct methods to analyse the magnitude, scale and determinants of mutation rate variation. This has enabled us to tease apart the evolutionary and mutational forces, whilst directly quantifying the variation in the human mutation rate at different scales; at large scales the variation appears to be quite modest, however at the single nucleotide scale there is potentially huge cryptic variation in the mutation rate. I envisage that within the near future, the increase in de novo mutations coming from pedigree studies will allow for even greater understanding. I extend this work into somatic tissues, however due to the quality of data and heterogeneity of samples and cell types, the primary findings lean towards highlighting areas of improvement for next genereation sequencing (NGS) pipelines - I show ~4% of all single nucleotide variants from cancers appear to be errors - and develop methods with which future studies could provide more insight. With these methods and the ever increasing flow of somatic single nucleotide variants, coupled with the continual improvements in NGS technology, it should soon be possible to provide accurate answers to the questions posed of somatic mutation rate variation in this thesis.611QH0426 GeneticsUniversity of Sussexhttps://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.714797http://sro.sussex.ac.uk/id/eprint/68212/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 611
QH0426 Genetics
spellingShingle 611
QH0426 Genetics
Smith, Thomas C. A.
Within genome variation of germ-line and somatic mutation
description Variation in the mutation rate along the human genome, if not properly understood and accounted for, has the potential to confound evolutionary studies, produce spurious driver candidates in cancer studies, and hinder the diagnostics aimed at understanding the etiologies of genetic diseases. In this thesis I consider mutation rate variation in both the germ-line and somatic tissues, at varying scales. In the germ-line, the major advance of this thesis over previous works is use of direct methods to analyse the magnitude, scale and determinants of mutation rate variation. This has enabled us to tease apart the evolutionary and mutational forces, whilst directly quantifying the variation in the human mutation rate at different scales; at large scales the variation appears to be quite modest, however at the single nucleotide scale there is potentially huge cryptic variation in the mutation rate. I envisage that within the near future, the increase in de novo mutations coming from pedigree studies will allow for even greater understanding. I extend this work into somatic tissues, however due to the quality of data and heterogeneity of samples and cell types, the primary findings lean towards highlighting areas of improvement for next genereation sequencing (NGS) pipelines - I show ~4% of all single nucleotide variants from cancers appear to be errors - and develop methods with which future studies could provide more insight. With these methods and the ever increasing flow of somatic single nucleotide variants, coupled with the continual improvements in NGS technology, it should soon be possible to provide accurate answers to the questions posed of somatic mutation rate variation in this thesis.
author Smith, Thomas C. A.
author_facet Smith, Thomas C. A.
author_sort Smith, Thomas C. A.
title Within genome variation of germ-line and somatic mutation
title_short Within genome variation of germ-line and somatic mutation
title_full Within genome variation of germ-line and somatic mutation
title_fullStr Within genome variation of germ-line and somatic mutation
title_full_unstemmed Within genome variation of germ-line and somatic mutation
title_sort within genome variation of germ-line and somatic mutation
publisher University of Sussex
publishDate 2017
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.714797
work_keys_str_mv AT smiththomasca withingenomevariationofgermlineandsomaticmutation
_version_ 1718992229094129664